SpaceX vs. S&P 500 ETF: Here's Which One History Says Is More Likely to Outperform

SpaceX’s IPO-priced pop has faded: the stock is down nearly 21% from its June 16 peak despite setting a record as the largest IPO by market cap. The article highlights that SpaceX is still unprofitable and described as overvalued on key metrics, with near-term volatility expected. It argues that historically most mega-IPOs underperform the S&P 500—collectively lagging by a median 127 percentage points—making the S&P 500 ETF the more stable alternative for long-term investors.

Analysis

This is less a SpaceX-specific call than a signal that the market is already taxing narrative premium in late-stage growth. The first public repricing usually reflects supply mechanics more than fundamentals: insider monetization, limited public float, and the market’s realization that cash-burning “category killers” have to earn their multiple in public rather than privately. That tends to pressure the entire unprofitable-growth complex and any adjacent names that trade on future optionality rather than current FCF.

The cleaner relative winners are profitable, liquid quality compounds such as META and NVDA, which benefit when capital rotates away from long-duration stories toward self-funding franchises. COIN is more vulnerable than it looks because it often trades like a retail/speculative beta proxy; if the market decides mega-hyped IPOs deserve lower terminal multiples, COIN’s own narrative premium can compress faster than earnings estimates move. NDAQ is a mixed read-through: weaker IPO appetite hurts issuance economics, but more volatility and hedging can partially offset that with higher trading activity.

The catalyst path is days-to-weeks for sentiment, but 1-3 months for the more important test: any disclosure that translates hype into margin structure, customer concentration, or funding runway. The contrarian risk is that the market is underpricing scarcity and strategic value; if a credible path to profitability appears, or if another strategic round validates a higher private mark, the de-rating can reverse quickly. Absent that, the stock likely behaves like other post-debut trophy assets: a strong brand with a long period of valuation digestion.

Key Decisions for Investors

• Long META / short SPCX on a 3-6 month horizon; use rallies in SPCX to initiate. Risk/reward favors quality vs narrative if public investors keep demanding free-cash-flow proof before paying premium growth multiples.
• Long NVDA / short SPCX as a higher-beta version of the same quality-vs-optionality theme. Stop if SPCX stabilizes on credible profitability disclosures or if NVDA multiple compresses on AI capex fatigue.
• If you want a broader de-risk trade, overweight SPY/VOO versus any basket of speculative post-IPO growth names for the next 1-3 months. This is a lower-conviction, lower-maintenance expression of the same factor rotation.
• Avoid initiating fresh long exposure in SPCX until the first earnings call clarifies gross margin, burn rate, and financing needs. Missing data is the key risk; a positive surprise on any of those metrics is the main falsifier.
• Watch COIN as a tell for speculative appetite. If COIN underperforms on the next broad market selloff, it confirms that the market is punishing duration risk rather than just one company.